« Back to Record
Citation APA

Hamilton, A., Larsimont, D., Paridaens, R., Drijkoningen, M., Van de Vijver, M. J., Bruning, P., Hanby, A., Houston, S., Treilleux, I., Guastalla, J. P., Van Vreckem, A., Sylvester, R., & Piccart-Gebhart, M. (2000). A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. Clinical breast cancer, 1(3), 233-40; discussion 241-2.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55276

Hamilton, A., Larsimont, D., Paridaens, R., Drijkoningen, M., Van de Vijver, M. J., Bruning, P., Hanby, A., Houston, S., Treilleux, I., Guastalla, J. P., Van Vreckem, A., Sylvester, R., & Piccart-Gebhart, M. (2000). A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. Clinical breast cancer, 1(3), 233-40; discussion 241-2.